首頁
Absorption Systems, LLC

3月 2026Absorption Systems, LLC的市場佔有率分析

Pharmaron is a global Life Science Contract Research Organization dedicated to to supporting drug development and the life sciences industry.

健康 > 生物技術和製藥

域名absorption.com

成立年份1996

僱員51 - 200

年度營收$50M - $75M

Absorption Systems, LLC

Absorption Systems, LLC（包含公司地區）

absorption.com

查看更多網站流量與參與度資訊

Absorption Systems, LLC截至 3月 2026 的總收入為 50M - 75M

Absorption Systems, LLC 熱門網域產生的總收入

Absorption Systems, LLC 熱門網域 3 年內的總收入

Absorption Systems, LLC 熱門網域的總收入

absorption.com50M - 75M

透過銷售情報查看更多內容

Absorption Systems, LLC的熱門網域總造訪量

了解Absorption Systems, LLC市場觸達率與潛在市場影響力。

過去 3 個月的訪問總量

無可顯示數據

Absorption Systems, LLC的熱門網域平均造訪時長

分析Absorption Systems, LLC參與度指標。

過去 3 個月平均造訪時長

無可顯示數據

Absorption Systems, LLC的熱門網域平均頁面瀏覽量

了解Absorption Systems, LLC如何保持使用者的參與度、培養其興趣，並鼓勵他們採取下一步。

過去 3 個月平均頁面瀏覽量

無可顯示數據

Absorption Systems, LLC按網域劃分的熱門競爭對手

3月 2026的熱門類似網站，依相似度排名

accessbio.com公司名Access Bio, Inc.僱員51 - 200總部美國, 新澤西州, Somerset年度營收$25M - $50M訪問總量--健康 > 生物技術和製藥

使用的熱門技術Absorption Systems, LLC

这些是Absorption Systems, LLC顶级域名使用的行业网站技术

付款與貨幣 (7)

Cart Functionality

小工具 (6)

Twemoji

轉換與分析 (5)

Google Analytics

付費廣告 (4)

DoubleClick

更多技術

12

檢視所有

新聞與訊號來自Absorption Systems, LLC

透過 Similarweb 銷售訊號提醒，每當目標受眾出現新的機會或威脅時，你就會收到每日更新的已識別購買訊號。

新聞Absorption expands offices in Massachusetts, United States, Northern America, Americas.Absorption Systems has expanded its Massachusetts operation with a 24,000-square-foot lease at 12 Cabot Road, in Woburn’s robust life sciences community.

新聞Pharmaron Beijing Co. Ltd. acquires Absorption for $138M.The move comes shortly after Pharmaron bought out Absorption Systems in the U.S., paving the way for a cell and gene therapy platform that runs the gamut from early research to commercial manufacturing.

新聞Absorption signs new client U.S. Food and Drug Administration.Absorption Systems, a global leader in translational medicine, pharmacokinetic testing of drugs, and cell and gene therapy, announces that it has been awarded a 2-year contract for a total amount of approximately $300,000 by the U.S. Food and Drug Administration (FDA).